Third Harmonic Financials
| THRD Stock | USD 12.76 0.35 2.67% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.0164 | 0.0147 |
|
| |||||
| Current Ratio | 25.72 | 50.2853 |
|
|
The essential information of the day-to-day investment outlook for Third Harmonic includes many different criteria found on its balance sheet. An individual investor should monitor Third Harmonic's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Third Harmonic.
Net Income |
|
Third | Select Account or Indicator |
Understanding current and past Third Harmonic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Third Harmonic's financial statements are interrelated, with each one affecting the others. For example, an increase in Third Harmonic's assets may result in an increase in income on the income statement.
Please note, the presentation of Third Harmonic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Third Harmonic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Third Harmonic's management manipulating its earnings.
Third Harmonic Stock Summary
Third Harmonic competes with Sensei Biotherapeutics, NextCure, Nuvation Bio, Cullinan Oncology, and Edgewise Therapeutics. Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts. Third Harmonic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US88427A1079 |
| CUSIP | 88427A107 |
| Location | California; U.S.A |
| Business Address | 1700 Montgomery Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.thirdharmonicbio.com |
| Phone | (209) 727 2457 |
| Currency | USD - US Dollar |
Third Harmonic Key Financial Ratios
| Return On Equity | -0.14 | ||||
| EBITDA | (30.79 M) | ||||
| Net Income | (30.82 M) | ||||
| Cash Per Share | 25.53 X | ||||
| Debt To Equity | 7.81 % |
Third Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Third Harmonic's current stock value. Our valuation model uses many indicators to compare Third Harmonic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Third Harmonic competition to find correlations between indicators driving Third Harmonic's intrinsic value. More Info.Third Harmonic Bio is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . At present, Third Harmonic's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Third Harmonic by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Third Harmonic Bio Systematic Risk
Third Harmonic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Third Harmonic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Third Harmonic Bio correlated with the market. If Beta is less than 0 Third Harmonic generally moves in the opposite direction as compared to the market. If Third Harmonic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Third Harmonic Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Third Harmonic is generally in the same direction as the market. If Beta > 1 Third Harmonic moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Third Harmonic Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Third Harmonic's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Third Harmonic growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Third Harmonic December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Third Harmonic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Third Harmonic Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Third Harmonic Bio based on widely used predictive technical indicators. In general, we focus on analyzing Third Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Third Harmonic's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.9 | |||
| Information Ratio | 0.0176 | |||
| Maximum Drawdown | 25.76 | |||
| Value At Risk | (6.74) | |||
| Potential Upside | 8.35 |
Complementary Tools for Third Stock analysis
When running Third Harmonic's price analysis, check to measure Third Harmonic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Third Harmonic is operating at the current time. Most of Third Harmonic's value examination focuses on studying past and present price action to predict the probability of Third Harmonic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Third Harmonic's price. Additionally, you may evaluate how the addition of Third Harmonic to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |